Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-017589
Filing Date
2025-06-17
Accepted
2025-06-17 18:31:31
Documents
1
Period of Report
2025-06-15

Document Format Files

Seq Description Document Type Size
1 form4-06172025_100627.html 4  
1 form4-06172025_100627.xml 4 5708
  Complete submission text file 0001415889-25-017589.txt   7311
Mailing Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Issuer) CIK: 0001370053 (see all company filings)

EIN.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O RELYPSA, INC. 700 SAGINAW DR. REDWOOD CITY CA 94063
Business Address
Orwin John A (Reporting) CIK: 0001477384 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37985 | Film No.: 251054641